Jardiance (empagliflozin) is a prescription drug that’s used to manage blood sugar levels and lower certain risks. The drug comes as an oral tablet. It’s usually taken once per day.

Farxiga and Jardiance are both used along with exercise and a balanced diet to manage blood sugar levels in adults with type 2 diabetes. Each drug also has some additional uses. The chart below ...

Diabetes, a chronic condition that occurs when the blood sugar level gets too high, may lead to weight loss or weight gain.

The Food and Drug Administration approved Eli Lilly’s Jardiance (empagliflozin) for treating adults with chronic kidney disease (CKD) on Friday morning. The agency approved 10 mg tablets of Jardiance ...

Boehringer Ingelheim and Eli Lilly have received the Food and Drug Administration's green light for Jardiance (empagliflozin) 10 mg tablets to reduce the risk of sustained decline in estimated ...

Jardiance had a 28% relative risk reduction for kidney disease progression vs. placebo. The drug also showed a significant reduction in hospitalization risk in patients with CKD. The FDA approved ...

The U.S. Food and Drug Administration has approved the use of Jardiance 10 mg and 25 mg tables to lower blood sugar along with diet and exercise in children aged 10 years and older with type 2 ...